Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neuroleptic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT01164059
What this trial is testing

Clinical Effectiveness of Newer Antipsychotics in Comparison With Conventional Antipsychotics in Schizophrenia

Who this might be right for
Schizophrenia
University of Bremen 149
Large-scale testing (Phase 3)Study completedNCT00412373
What this trial is testing

Evaluation of Effectiveness and Safety of Flexible-dose Paliperidone Extended Release in Patients With Schizoaffective Disorder.

Who this might be right for
Schizoaffective DisorderPsychotic Disorder
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 307
Post-approval studies (Phase 4)Study completedNCT00833976
What this trial is testing

Omega-3 Fatty Acids (Lovaza) for Second Generation Antipsychotic-Associated Hypertriglyceridemia

Who this might be right for
High TriglyceridesHypercholesterolemiaSchizophrenia+2 more
Massachusetts General Hospital 65
Not applicableUnknownNCT01236274
What this trial is testing

The Risk of Myocardial Infarction in Users of Antipsychotic Agents

Who this might be right for
Myocardial Infarction
London School of Hygiene and Tropical Medicine 90,000
Large-scale testing (Phase 3)WithdrawnNCT02212613
What this trial is testing

Brexpiprazole (OPC 34712) Trial in the Treatment of Adults With Major Depressive Disorder and Irritability

Who this might be right for
Major Depressive Disorder and Irritability
Otsuka Pharmaceutical Development & Commercialization, Inc.
Post-approval studies (Phase 4)Study completedNCT02237417
What this trial is testing

Impact of Aripiprazole Once Monthly Medications on Changes in Brain Structure and Metabolism

Who this might be right for
Schizophrenia
University of Utah 47
Not applicableUnknownNCT05647980
What this trial is testing

Transmural Collaborative Care Model for CVRM and Medication Review for Patients Using Antipsychotics

Who this might be right for
Mental Disorders, Severe
Radboud University Medical Center 480
Not applicableStudy completedNCT00206960
What this trial is testing

Dopaminergic, Functional, Structural, and Cognitive Disturbances in First-episode Schizophrenia

Who this might be right for
Schizophrenia
Birte Glenthoj 56
Early research (Phase 1)Study completedNCT00892320
What this trial is testing

The Effect of Food on the Pharmacokinetics of ER OROS Paliperidone in Healthy Japanese Volunteers

Who this might be right for
Schizophrenia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 20
Not applicableStudy completedNCT00627510
What this trial is testing

Routine Plasma Level Determination to Compare Actual vs Expected Plasma Levels at Psychiatric Inpatient Admission

Who this might be right for
DepressionAffective Disorders, Psychotic
Medical University Innsbruck 161
Not applicableStudy completedNCT00283517
What this trial is testing

A Registry of Treatment Adherence for Patients With Schizophrenia

Who this might be right for
SchizophreniaPsychotic Disorders
Janssen-Cilag, S.A. 2,046
Not applicableLooking for participantsNCT06814314
What this trial is testing

AP Metabolism Transcriptomics

Who this might be right for
Neurodevelopmental DisordersIrritability
IRCCS Eugenio Medea 100
Not applicableStudy completedNCT00716755
What this trial is testing

Minimizing Doses of Antipsychotic Medication in Older Patients With Schizophrenia.

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorder+2 more
Centre for Addiction and Mental Health 45
Not applicableUnknownNCT02986490
What this trial is testing

Magnesium Variations and Cardiometabolic Risk in Patients With Antipsychotic Drugs

Who this might be right for
SchizophreniaSchizoaffective DisorderBipolar Disorder
University Hospital, Montpellier 100
Large-scale testing (Phase 3)Study completedNCT01625897
What this trial is testing

A Long-Term Study of MP-214 in Patients With Chronic Phase or Elderly Schizophrenia

Who this might be right for
Schizophrenia
Tanabe Pharma Corporation 125
Post-approval studies (Phase 4)Study completedNCT00654576
What this trial is testing

Effectiveness of Antipsychotic Combination With Psychosocial Intervention on Outcome of Patients With Schizophrenia

Who this might be right for
Schizophrenia
Central South University 1,400
Large-scale testing (Phase 3)Study completedNCT01211522
What this trial is testing

The Modifying the Impact of ICU-Associated Neurological Dysfunction-USA (MIND-USA) Study

Who this might be right for
DeliriumImpaired CognitionLong Term Psychologic Disorders
Vanderbilt University Medical Center 566
Testing effectiveness (Phase 2)Looking for participantsNCT07374419
What this trial is testing

Atamparib in Patients With Advanced Solid Tumors

Who this might be right for
NSCLC AdenocarcinomaSolid Tumor
Nerviano Medical Sciences (Shanghai) Ltd. 178
Post-approval studies (Phase 4)Study completedNCT00232336
What this trial is testing

Quetiapine for Cocaine Use and Cravings

Who this might be right for
Cocaine-Related DisordersSubstance-Related Disorders
Seattle Institute for Biomedical and Clinical Research 42
Large-scale testing (Phase 3)Study completedNCT01794429
What this trial is testing

Treatment of Antipsychotic-associated Obesity With a GLP-1 Analogue

Who this might be right for
ObesityMetabolic Syndrome XDrug-induced Obesity+1 more
Bjorn H. Ebdrup 45
Next Page